Alopecia

Embed Size (px)

DESCRIPTION

causes and types of alopecia

Citation preview

  • SEMINAR ON ALOPECIAChairperson: Dr. Shahab Uddin Ahmed Chowdhury. Associate Professor & Head of the dept. Department of Dermatology, MMC.

    Speakers : Dr. Mohammad Shoeb Khan, MD (Part-II) & Dr. Mohammed Saiful Islam Bhuiyan, MD (Part-II), FCPS (Part-II) Medical Officers, Department of Dermatology, MMCH.

    Date & Time : 5th April, 2005 at 2.00 pm.

    Organized by : Department of Dermatology, MMCH. & Renata Limited

  • HAIR AND HAIR FOLLICLE

  • INTRODUCTIONHairs are keratinized elongatedstructures derived from invaginations ofepidermis and project out from most ofthe body surface.

  • AREAS WITHOUT HAIR:

  • RACIAL PREVALENCE :Whites are hairiest.Asians are least hairy and blacks fall in between.

  • TYPES OF HAIR Morphologically :Straight : Asians , whites.Spiral :Blacks, whites.Helical : Whites.Wavy : Whites.

  • HAIR TYPES (Contd.)Fetal hair -Lanugo hair : soft, fine, lightly pigmented hairs.Adult hair -Vellus hair : fine hairs cover most of the body of youngsters and adults.Terminal hair: long, coarse, pigmented hairs with larger diameters.

  • NUMBER OF HAIRS Scalp : about 1,00,000 hairs.Face : about 600 hairs /cm2.Rest of the body : about 60 hairs/cm2.

  • LENGTH, WIDTH AND GROWTH RATE

    Length : range from 1 meter.Average uncut scalp hair : 25 100 cm. (exceptionally 170 cm)Width : from 0.005 to 0.06mm.Growth rate: about 1 cm/ month (terminal hair).

  • FUNCTIONS

    1.Protects body surface from external injury.2.Helps in sensory function.Psycho social importance.Forensic importance.i.Identification of race, sex, age and religion. ii.Cause of death- can be determined. iii. Time of death- can be determined. 5.Assist thermo- regulation: mainly in lower animals.

  • STRUCTURE OF HAIR AND HAIR FOLLICLE:

  • DEVELOPMENT OF HAIR Ectodermal origin-1.Hair bud develops from epidermis and penetrates the dermis.2.Hair shaft grows from cells in the centre of hair bud.

  • DEVELOPMENT OF HAIR (Contd.)

    3.Inner root sheath develops from cells in the periphery of hair bud.Mesodermal origin: Outer root sheath.First hair come is lanugo hair at eyebrow and upper lip at twelve weeksof gestation.

  • DEVELOPMENT OF HAIR (Contd.)

    3.Inner root sheath develops from cells in the periphery of hair bud.Mesodermal origin : Outer root sheath.First hair to come is lanugo hair at eyebrow and upper lip at 12 weeks of gestation.

  • HAIR EMBRYOLOGY

  • HAIR CYCLEIt is believed that each hair follicle goesthrough 10-20 hair cycle in a life time. There are four phases-Anagen :growing phase.Catagen:involuting phase. Telogen :resting phase.Exogen :hair shedding phase.

  • ANAGEN (GROWING PHASE)Last for about 1000 days.Follicular cells grow, divide and become keratinized to form growing phase.A darkly pigmented portion is evident just above the hair bulb.

  • CATAGEN (INVOLUTING PHASE)Lasts for about 10 days.Scalp hairs show a gradual thinning and decrease of the pigment.Melanocytes cease producing melanin.Matrix keratinocytes abruptly cease proliferating so that lower follicle involutes and regresses.

  • TELOGEN (RESTING PHASE)Lasts for about 100 days.Club-shaped proximal end shed from the follicle during telogen or subsequent anagen.Growth of a new anagen hair leads to shedding of any remaining telogen hair.But new hair does not push out the hair from the previous cycle.

  • EXOGEN (HAIR SHEDDING PHASE)Recently added phase.The term describes relationship between hair shaft and base of telogen follicle. Hairs can be retained for more than one cycle.Shedding phase is most likely independent of anagen and telogen.

  • PIGMENTATION OF HAIR Hair color is determined by melanocytes. Melanocytes are present in the bulb. Melanocytes feed melanosomes mainly to the medulla and cortex. Melanocytic follicles produce melanin- . eumelanin (dominant in brown-black hairs) . phaeomelanin (dominant in red-blond hairs)

  • Greying of hair due to decreased number and activities of melanocytes. Vitiligo due to destruction of melanocytes. Albinism due to inactivity of melanocytes.

    PIGMENTATION OF HAIR (Contd.)

  • ALOPECIA Absence or loss of hair especially of the scalp. Pathophysiology of hair loss :

    1. Production failure Failure to produce or continue to produce a normal hair follicle.2. Aberration of Normal hair cycle. Production of a normal hair shaft.3. Destruction of Hair follicle.

  • CLASSIFICATION OF ALOPECIA FOCAL HAIR LOSS Non-Scarring:A. Abnormality of cycling-i. Alopecia areata.ii. Syphilitic alopecia.B.Production decline-i. Androgenetic alopecia.ii. Triangular alopecia.

  • FOCAL HAIR LOSS (Contd.)C.Hair breakage-i. Trichotillomania.ii. Tinea capitis.iii. Traction alopecia.iv. Primary or acquired hair shaft abnormality.

  • SCARRING ALOPECIALymphocytic-i.Chronic Cutaneous LE (DLE).ii. Lichen planopilaris.iii. Classic pseudopellade of Brocq.iv. Alopecia mucinosa.v. Central centrifugal cicatricial alopecia.vi. Keratosis follicularis spinulosa decalvans.

  • SCARRING ALOPECIA (CONTD.)

    B. Neutrophilic i. Folliculitis decalvans. ii.Dissecting folliculitis/cellulitis.C. Mixed-i. Folliculitis (acne) keloidalis.ii. Folliculitis (acne) necrotica.iii. Erosive pustular dermatitis.

  • Diffuse Hair Loss Abnormality of cycling i. Alopecia areata.ii. Telogen effluvium.iii. Anagen effluvium.iv. Loose anagen syndrome.Hair shaft abnormality-i. Hair breakage.ii. Unruly hair.

  • Diffuse Hair Loss (Contd.)C.Failure of follicle production-i. Congenital universal atrichia.ii. Alrichia with papular lesions.iii. Hereditary vitamin-D- resistant rickets.

  • ALOPECIA AREATADefinition:Rapid and complete loss of hair in one or most often several round or oval patches, usually on the scalp, bearded area, eyebrows, eye lashes and less commonly on other hairy areas of the body.

  • ALOPECIA AREATA

  • ALOPECIA AREATA

  • ALOPECIA AREATA(Contd.)Epidemiology:Approximately 1.7% of the population will experience an episode of alopecia aerata during their life time.

  • ALOPECIA AREATA (Contd.) Etiology Exact cause is still unknown. It is an autoimmune disease-- Mediated by the cellular arm (T- cell, macrophages ).- Modified by genetic factors (HLA-R4,DR11,DQ7)

  • ALOPECIA AREATA (Contd.)-Triggered by environmental factors- Trauma. Neurogenic inflammation. Infections agents.

  • Aberrant expression of MHC (due to failure of repression)

    Release of cytokines

    Aberrant expression of adhesion molecules

    ETIOPATHOGENESIS

  • Production of follicular auto- antigen (Kerationcyte and melanocyte origin)

    Follicular damage in anagen and rapid premature transformation to telogen.

    Haematopoietic cell migration (T-cell)

  • FOUR DISTINCT STAGES OF ALOPECIA AREATA i.Acute hair loss.ii.Persistant (Chronic) baldness.iii.Partial telogen to anagen conversion(incomplete revcovery).iv.Normal recovery.

  • CLINICAL FEATURE

    Rapid and complete loss of hair in one or several patches.Site Scalp, bearded area, eyebrows, eye lashes and less commonly other areas of body.Size Patches of 1-5 cm in diameter.

  • CLINICAL FEATURE (CONTD.)

    Exclamation point hair- at the periphery of hair loss, there are broken hairs, whose distal ends are broader than the proximal end. !

  • EXCLAMATION MARK HAIRS

  • CLINICAL FEATURE (CONTD.)

    Few resting hairs may be found within the patches.Going gray overnight- a mysterious phenomenon is observed in fulminant alopecia areata.In about 10% cases of long standing extensive alopecia areata, some nail changes develop.

  • EXTENSIVE PATCHY ALOPECIA AREATA.

  • DIFFUSE PATTERN OF HAIR LOSS IN ALOPECIA AREATA

  • CLINICAL FEATURE (CONTD.)

    Alopecia totalis Total loss of scalp hair.

    Alopecia universalis Loss of entire body hair including scalp hair.

    Ophiasis Loss of hair confluent along the temporal and occipital scalp.Sisaipho- Loss of hair of entire scalp except temporal and occipital area.

  • ALOPECIA UNIVERSALIS

  • ALOPECIA TOTALIS

  • OPHIASIS PATERN OF ALOPECIA AREATA

  • ASSOCIATED DISEASEHigher incidence of alopecia areata inpatients of-1.Atopic dermatitis.2.Autoimmune disease * SLE * Thyroiditis. * Myasthenia gravis. * Vitiligo.3.Lichen planus.4.Down syndrome.

  • HISTOLOGY Peribulbar, Perivascular and outer-root sheath infiltration with T-cells and macrophages.The follicular size are diminished and identified in more superficial dermis.

  • DIFFERENTIAL DIAGNOSIS 1. Tinea capitis.2.Trichotilomania.3.Secondary syphilis 4.Congenital triangular alopecia.5.Alopecia neoplastica.6.Early lupus erythematosus.

  • TREATMENT

    Spontaneous recovery is extremely common for patchy alopecia areata.

    For localized patchy alopecia areata- Steroid- both local (intralesional and topical) and systemic (in short course).

  • TREATMENT (CONTD.)- High potent topical steroid used as first line therapy.- Intralesional steroid given at 4-6 weeks interval.- Systemic steroid (Short course,
  • TREATMENT (CONTD.)If lack of response after several months therapy-Topical 1% Anthralin cream - applied for 15-20 minutes and then shampooed off the treated side.5% topical minoxidil as a single agent or as an adjuvant with topical Anthralin.PUVA.

  • TREATMENT (CONTD.)Contact sensitizer - Squaric acid dibutyle ester,- Diphencyprone,- Dinitrochlorobenzene.Psychological support.In extensive scalp hair loss- cosmetically expectable alternatives.

  • HEALED ALOPICIA UNIVERSALIS AFTER PUVA THERAPY

  • PROGNOSIS

    Poor prognostic marker- -Early onset (Prepubertal)-Extensive involvement.-Prolong duration (>5years)-Ophiasis.

  • ANDROGENETIC ALOPICIA

  • ANDROGENETIC ALOPICIA

  • ANDROGENETIC ALOPECIASynonyms : Male Pattern alopecia,Male pattern baldness,Common baldnessSecretarial alopecia.Definition :It is a very common, potentiallyreversible scalp hair loss that generally sparesparietal and occipital areas (Hippocraticwreath) of the scalp.

  • ANDROGENETIC ALOPECIA (Contd.)

    Age :Twenties or early thirties.sites : Chiefly vertex and frontotemporalregions.Etiopathogenesis:Exact mechanism is still unknown.Hereditary (Probably autosomal dominant) &Androgen (specifically dihydrotestesterone)

  • ETIOPATHOGENESIS (Contd.)

    Testesterone 5R Dihydrotesterone.5R has two Isozyme, 5R1 and 5R25R1 ubiquitously distributed in skin particularly in sebaceous gland.5R2 is found in outer root sheath and dermal papillae.

  • ANDROGEN

    Androgen - androgen receptor complex in cytoplasm

    transformation of receptor to expose DNA binding domain

    binds to androgen response element of DNA

    Transcription and translation

    certain effector protein,

  • ETIOPATHOGENESIS (Contd.) EFFECTS- Shortening of anagen and lengthening of telogen- Follicle become short and sclerosis of dermis and miniaturization or reduction of hair present.

  • CLINICAL FEATUREHair loss starts any time after puberty Whisker hairs first sign of impending male pattern alopecia, appear at the temple.Professors angle anterior hair line recedes backward on each side.Eventually entire top of the scalp become devoid of hair.

  • PATTERN OF HAIR LOSS

  • Androgenetic alopecia in womenEtiology :Genetic Predisposition,Androgen excess, Ovarian cause-- Polycystic ovarian syndrome,- Other ovarian tumor, . Unilateral benign microadenoma. . Leydig cell tumor . Hilar cell tumor.

  • ETIOLOGY (CONTD.)Adrenal cause - Congenital adrenal hyperplasia (androgenital syndrome) due to deficiency of 21 hydroxylase (most common)11- hygroxylase.3- hydroxysteroid dehydrogenase. - Tumor Adrenal adenomaCarcinoma.

  • CLINICAL FEATUREPattern of hair loss :Christmas tree pattern- diffuse and progressive reduction of density and diameter of hairs in the mid scalp.Maintenance of frontal hair lines with only slight recession.

  • ANDROGENETIC ALOPECIA IN WOMEN

  • CLINICAL FEATURE (CONTD.)

    Other evidence of androgen excess:Acne.Hirsutism.Menstrual irregularities.Majority of women with pattern hair loss have No increased serum androgen,No other sign symptom of androgen hypersensitivity.

  • TREATMENT1.Topical Minoxidil (2% & 5%)-non specific hair growth promoter affecting anagen induction.- M/A is not clear, its ca channel opener activity is important. 2.Systemic Finesteride (1mg daily).

  • TREATMENT (CONTD.)3.In women spironolactone ( >100 mg daily). - Flutamide (250-500 mg bid or tid). - Cyproterone actate.4. Surgical treatment- Micrograft & minigraft from non-androgen dependent site (occiput).

  • TELOGEN EFFLUVIUM It is a reaction pattern to a variety ofphysical and mental stressors representsa precipitous shift of a percentage ofanagen hairs to telogen.

  • Causes of Telogen Effluvium Endocrine-Hypo- or hyperthyroidism.-Postpartum.-Peri- or postmenopausal state.Nutritional-Biotin deficiency.-Caloric deprivation.-Essential fatty acid deficiency.-Iron deficiency.-Protein deprivation.-Zinc deficiency.

  • Causes of Telogen Effluvium (Contd.)

    DrugsAngiotensin-converting enzyme inhibitors.Anticoagulants.Antimitotic agents.Benzimidazoles.Beta blockers.InterferonLithium

  • Oral contraceptives.Retinoids.Vitamin A excess.Physical stressAnemiaSurgery.Systemic illness.Psychological stressCauses of Telogen Effluvium (Contd.)

  • Events related to pathogenesis of telogen effluviumShort anagen- by drugs, fever, physiological stress. Prolonged anagen- Pregnancy.Conversion of telogen follicle to anagen follicle.

  • Pathology> 12% to 15% of terminal follicles are in telogen.Follicle itself is not diseased.No inflammation or dystrophic changes.

  • CLINICAL PRESENTATION

    Lots of hairs coming out by the roots complained by patient.Diffuse hair loss with clinically perceptible thinning of hairs usually 3-5 weeks of inciting signal and shedding continue for about 3-4 month after removal of inciting cause.150 to > 400 hair loss daily. Hair density may take 6-12 months to return to base line. Pull test.Clip test.

  • TREATMENTNo specific therapy.In majority cases hair will grow spontaneously within few month after removing inciting cause.In some patients with chronic telogen effluvium-- 5% minoxidil solution, 70% success in man .- For Premenopausal women, 5% minoxidil solution + cyproterone acitate 50 mg from day 5 to 15 of menstrual cycle taken together with ethynnyl estradiol (0.035 mg/day).

  • TREATMENT (CONTD.) For post menopausal women,- Cyproterone acetate 50 mg/day.- Spironolactone (50- 100 mg/day) or flutamide 125- 250 mg/ day alternative to cyproterone acetate.

  • TRICHTILLOMANIAA neurotic practice of plucking or breaking hair from scalp or eyelash resulting usually localized or widespread areas of alopecia contains hairs of varying length.Mostly girls under age of 10 years.Disturbed mother- child relationship.

  • TRICHOTILOMANIA

  • TRICHOTILOMANIA IN A WOMEN

  • ALOPECIA SYPHILITICATypical motheaten appeorance on the occipital scalp or generalized thinning of hairs or both.Eyebrows, eyelash and body hairs also involved.It may be one or sole cutaneus manifestation of secondary syphilis.Treatment of syphilis may reverse the hair loss.

  • ALOPICIA OF SECONDARY SYPHILIS